SAHPRA Recalls Affected batches of Citro-Soda Regular Following Safety Concerns
Pretoria, 24 March 2026 – The South African Health Products Regulatory Authority (SAHPRA) today brie...
24 March, 26
Looking for a document – search here:
News and Updates
-
-
SAHPRA to brief media on the recall of specified batches of Citro-Soda Regular amid safety concerns
Pretoria, 20 March 2026 – The South African Health Products Regulatory Authority (SAHPRA) will brief...
20 March, 26 -
Powering Excellence: SAHPRA fuels future Innovators with Tech Boost at SMU Awards
The South African Health Products Regulatory Authority (SAHPRA) reinforced its role as a champion of...
25 February, 26 -
SAHPRA Responds to Carte Blanche Report on Alleged GMP Non-compliance at Adcock Ingram Clayville Facility
Pretoria, 23 February 2026 – The South African Health Products Regulatory Authority (SAHPRA) has not...
23 February, 26
Media
Stay up to date with our latest news, media coverages, interviews and announcements on our Video Portal.
Databases and Registers
OTC Medicine Information
The Medicines’ Online Directory provides healthcare professionals and the consumer with a guide to all SAHPRA registered over-the counter (OTC) medicines that are available in South Africa without a doctor’s prescription.
Safety alerts
-
Warfarin and Tramadol – Harmful Drug-Drug Interaction
The South African Health Products Regulatory Authority (SAHPRA) would like to inform healthcare prof...
06 June, 25 -
IV Tranexamic acid – Administration error via the intrathecal route
There have been several cases around the world in which Tranexamic acid has been administered intrat...
21 December, 23 -
A Signal Of Myocarditis / Pericarditis Associated With Pfizer-biontech’s Covid-19 Vaccine, Comirnaty (Bnt162b2)
The South African Health Products Regulatory Authority (SAHPRA) would like to inform you of a signal...
19 October, 21 -
Risk of Drug-Induced Liver Injury associated with the use of Esbriet®
In collaboration with the South African Health Products Regulatory Authority (SAHPRA), Roche Product...
10 November, 20
Whistleblower
The hotline has been established with the aim of enhancing an honest work ethic and simultaneously providing the public with a mechanism to bring any unethical business practices to the attention of management.
Product Recalls
Bayer has detected a risk for the formation of nitrosamine (N-Nitroso-Meglumine) in Gastrografin/Urografin.
Bayer has detected a risk for the formation of nitrosamine (N-Nitroso-Meglumine) in Gastrografin/Urografin.
This recall is initiated due to an out-of-specification result in the Aerodynamic Assessment of Fine Particles test [by Andersen Cascade Impactor test (APSD)] for Fluticasone Propionate during stability testing.
Social Media Feeds